07 May, 2024

CereVasc Receives FDA IDE Approval for the STRIDE Pivotal Study of the eShunt System for Treatment of Normal Pressure Hydrocephalus

cerevasc2024-05-28T21:43:24+00:00May 7th, 2024|

Read More

07 Feb, 2024

CereVasc’s eShunt® System to be Presented at the International Stroke Conference by Dr. Pedro Lylyk

cerevasc2024-05-10T14:17:27+00:00February 7th, 2024|

Read More

23 Jan, 2024

Prevalence of Possible Idiopathic Normal Pressure Hydrocephalus in Sweden

cerevasc2024-02-16T22:39:04+00:00January 23rd, 2024|

Read More

23 Jan, 2024

CereVasc’s eShunt® System Study Data Presented at the ABC WIN Seminar

cerevasc2024-05-10T14:32:14+00:00January 23rd, 2024|

Read More

27 Oct, 2023

Cerebral venous disorders: Diagnosis and endovascular management

cerevasc2024-08-01T15:16:08+00:00October 27th, 2023|

Read More

10 Feb, 2021

First patient treated in CereVasc clinical trial of eShunt™ System for communicating hydrocephalus

cerevasc2023-02-14T15:48:38+00:00February 10th, 2021|

Read More

01 Oct, 2020

Anatomical characterization of the inferior petrosal sinus and adjacent cerebellopontine angle cistern for development of an endovascular transdural cerebrospinal fluid shunt

cerevasc2024-08-01T15:18:29+00:00October 1st, 2020|

Read More

04 Nov, 2019

CereVasc, LLC Receives Approval to Initiate First-in-Human Clinical Study of the eShunt System

cerevasc2023-02-14T15:48:39+00:00November 4th, 2019|

Read More

25 Sep, 2017

Initial Results of the eShunt System Presented at the International Society of Hydrocephalus and Cerebrospinal Fluid Disorders Annual meeting in Kobe, Japan

cerevasc2023-02-14T15:48:40+00:00September 25th, 2017|

Read More

08 Dec, 2015

Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

cerevasc2023-12-20T22:35:03+00:00December 8th, 2015|

Read More